Skip to content

Effectiveness of 2% Lignocaine, 4% Tetracaine, and Ice for Topical Anesthesia in Greater Palatine Nerve Block: A Randomized Controlled Trial

Comparing the Effectiveness of 2% Lignocaine, 4% Tetracaine, and Ice as Topical Anesthesia for Greater Palatine Nerve Block: A Three-Arm Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074647
Enrollment
72
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z768- Persons encountering health services in other specified circumstances Health Condition 2: Z768- Persons encountering health services in other specified circumstances

Interventions

Intervention1: 4% Tetracaine, and Ice as Topical Anesthesia for Greater Palatine Nerve Block: here we are using 4% Tetracaine, and Ice as Topical Anesthesia prior to Greater Palatine Nerve Block to c

Sponsors

Geetanjali Dental & Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between age of 18-75 years of both genders. 2.Patients undergoing maxillary posterior teeth extractions. 3.Patients falling under ASA I and ASA II classification. 4.Subjects able and willing to provide well informed written consent and comply with study procedure.

Exclusion criteria

Exclusion criteria: 1.Patients receiving pre-op analgesia and sedation. 2.Patients in whom more than one attempt required to secure a successful nerve block.

Design outcomes

Primary

MeasureTime frame
1. Pain at the time of needle prick 2) SEM scaleTimepoint: intraoperative

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shallu Bansal

Geetanjali Dental and Research Insitute

drshallu23@gmail.com9116155666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026